Paraneoplastik Sendromların Nadir Örnekleri
Özet
Metin Pehlivan tarafından kaleme alınan bu çalışma, kanser hastalarının yaklaşık %10'unda görülen ve tümörün lokal etkilerinden bağımsız olarak gelişen paraneoplastik sendromların nadir örneklerini incelemektedir. Tümörlerin hormon, peptit, sitokin üretimi veya otoimmün mekanizmalarla tetiklenen bu sendromlar; kanser tanısından önce, tedavi sırasında veya sonrasında ortaya çıkabilmektedir. Çalışmada paraneoplastik sendromlar dört ana başlıkta ele alınmıştır: Endokrin sendromlar kapsamında IGF-2 üretimine bağlı hipoglisemi, acil müdahale gerektiren hiperkalsemi, karsinoid sendrom, akromegali ve hipertroidi açıklanmaktadır. Dermatolojik sendromlar başlığı altında paraneoplastik pemfigus, nekrolitik migratuar eritem, dermatomyozit, en sık mide kanserinde görülen akantozis nigrikans ve Basex sendromu yer almaktadır. Nörolojik sendromlar kulvarında ensefalomyelit, kronik gastrointestinal psödoobstrüksiyon, Lambert-Eaton myastenik sendromu ve sensöriyel nöropatiler incelenirken; hematolojik grupta ise tümör öz kaynaklı trombositoz ve sıklıkla timomaya eşlik eden saf eritroid dizi aplazisi değerlendirilmektedir. Çoğu paraneoplastik sendromun spesifik bir tedavisi bulunmamakla birlikte, temel yaklaşım altta yatan malignitenin tedavisi ve semptomların hafifletilmesine yöneliktir. Çoklu organ sistemlerini etkileyen bu karmaşık süreçlerin mekanizmalarının tam olarak anlaşılması adına gelecekte daha fazla bilimsel çalışmaya ihtiyaç duyulduğu vurgulanmaktadır.
Authored by Metin Pehlivan, this comprehensive study examines rare examples of paraneoplastic syndromes, which manifest in approximately 10% of cancer patients and arise from systemic tumor effects rather than direct local invasion. Triggered by tumor-derived hormones, functional peptides, cytokines, or autoimmune responses, these syndromes can emerge prior to, during, or following cancer therapy. The document categorizes these manifestations into four primary clinical groups: endocrine, dermatological, neurological, and hematological syndromes. Within the endocrine category, conditions such as IGF-2-induced hypoglycemia, severe hypercalcemia requiring urgent intervention, carcinoid syndrome, ectopic acromegaly, and hyperthyroidism are detailed. Cutaneous manifestations include paraneoplastic pemphigus, necrolytic migratory erythema, dermatomyositis, acanthosis nigricans, and acrokeratosis paraneoplastica. Neurological complications encompass encephalomyelitis, chronic gastrointestinal pseudo-obstruction, Lambert-Eaton myasthenic syndrome, and sensory neuropathies, predominantly linked to small cell lung cancer. Finally, hematological disorders like tumor-promoted thrombocytosis and thymoma-associated pure red cell aplasia are evaluated. The author underscores that most paraneoplastic syndromes lack specific targeted treatments; therefore, the cornerstone of management relies heavily on treating the underlying primary malignancy alongside managing clinical symptoms, indicating a vital necessity for further scientific research.
Referanslar
Sam AH, Salem V, Ogilvie AJ, Clements MR. Paraneoplastic hypoglycemia-"big" deal. Endocr Pract. 201;17(2):303-5.
Bodnar TW, Acevedo MJ, Pietropaolo M. Management of non-islet-cell tumor hypoglycemia: a clinical review. J Clin Endocrinol Metab. 2014;99(3):713-22.
Bergman PJ. Paraneoplastic hypercalcemia. Top Companion Anim Med. 2012;27(4):156-158.
Rosner MH, Dalkin AC. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia. Clin J Am Soc Nephrol. 2012;7(10):1722-1729. doi:10.2215/CJN.02470312
Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP. Carcinoid syndrome: update on the pathophysiology and treatment. Clinics (Sao Paulo). 2018;73(suppl 1):e490s. Published 2018 Aug 20.
Gade AK, Olariu E, Douthit NT. Carcinoid Syndrome: A Review. Cureus. 2020;12(3):e7186.
Faglia G, Arosio M, Bazzoni N. Ectopic acromegaly. Endocrinol Metab Clin North Am. 1992;21(3):575- 595.
Krug S, Boch M, Rexin P, et al. Acromegaly in a patient with a pulmonary neuroendocrine tumor: case report and review of current literature. BMC Res Notes. 2016;9:326.
Voigt W, Maher G, Wolf HH, Schmoll HJ. Human chorionic gonadotropin-induced hyperthyroidism in germ cell cancer--a case presentation and review of the literature. Onkologie. 2007;30(6):330-334.
Paolino G, Didona D, Magliulo G, et al. Paraneoplastic Pemphigus: Insight into the Autoimmune Pathogenesis, Clinical Features and Therapy. Int J Mol Sci. 2017;18(12):2532.
Stone SP, Buescher LS. Life-threatening paraneoplastic cutaneous syndromes. Clin Dermatol. 2005;23(3):301-306.
Kim JH, Kim SC. Paraneoplastic Pemphigus: Paraneoplastic Autoimmune Disease of the Skin and Mucosa. Front Immunol. 2019;10:1259.
Foss MG, Ferrer-Bruker SJ. Necrolytic Migratory Erythema.
Tolliver S, Graham J, Kaffenberger BH. A review of cutaneous manifestations within glucagonoma syndrome: necrolytic migratory erythema. Int J Dermatol. 2018;57(6):642-645.
Psomiadou V, Gkegkes ID, Iavazzo C. Dermatomyositis and/or polymyositis as a paraneoplastic manifestation of ovarian cancer: a systematic review. Contemp Oncol (Pozn). 2020;24(4):252-257.
Bientinesi R, Ragonese M, Pinto F, et al. Paraneoplastic Dermatomyositis Associated With Panurothelial Transitional Cell Carcinoma: A Case Report and Literature Review. Clin Genitourin Cancer. 2016;14(2):e199-e201.
Das A, Datta D, Kassir M, et al. Acanthosis nigricans: A review. J Cosmet Dermatol. 2020;19(8):1857- 1865.
Krawczyk M, Mykała-Cieśla J, Kołodziej-Jaskuła A. Acanthosis nigricans as a paraneoplastic syndrome. Case reports and review of literature. Pol Arch Med Wewn. 2009;119(3):180-183.
Roy B, Lipner SR. A Review of Nail Changes in Acrokeratosis Paraneoplastica (Bazex Syndrome). Skin Appendage Disord. 2021;7(3):163-172.
Valdivielso M, Longo I, Suárez R, et al. Acrokeratosis paraneoplastica: Bazex syndrome. J Eur Acad Dermatol Venereol. 2005;19(3):340-344.
Tirthani E, Said MS, Smith RG, et al. Paraneoplastic Encephalomyelitis.
Grativvol RS, Cavalcante WCP, Castro LHM, Nitrini R, Simabukuro MM. Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes. Curr Oncol Rep. 2018;20(11):92. Published 2018 Nov 10. doi:10.1007/s11912-018-0721-y
Lorusso L, Hart IK, Ferrari D, et al. Autonomic paraneoplastic neurological syndromes. Autoimmun Rev. 2007;6(3):162-168.
Kesner VG, Oh SJ, Dimachkie MM, Barohn RJ. Lambert-Eaton Myasthenic Syndrome. Neurol Clin. 2018;36(2):379-394.
Jayarangaiah A, Theetha Kariyanna P. Lambert Eaton Myasthenic Syndrome.
Antoine JC, Camdessanché JP. Paraneoplastic neuropathies. Curr Opin Neurol. 2017;30(5):513-520.
Gwathmey KG. Sensory neuronopathies. Muscle Nerve. 2016;53(1):8-19.
Lin RJ, Afshar-Kharghan V, Schafer AI. Paraneoplastic thrombocytosis: the secrets of tumor self- promotion. Blood. 2014;124(2):184-187.
Baranyai Z, Jósa V, Tóth A, et al. Paraneoplastic thrombocytosis in gastrointestinal cancer. Platelets. 2016;27(4):269-275. doi:10.3109/09537104.2016.1170112
Mangla A, Hamad H. Pure Red Cell Aplasia.
Means RT Jr. Pure red cell aplasia. Blood. 2016;128(21):2504-2509.
Xavier RD, Devaraj S, Sadasivam V, et al. Thymoma associated with pure red cell aplasia: a case report and literature review. Indian J Thorac Cardiovasc Surg. 2020;36(4):404-408.
